Prevalence and clinical implications of germline mutations among Jordanian patients with ovarian cancer. The Jordanian exploratory cancer genetics (Jo-ECAG) ovarian study.

Hikmat Abdel-RazeqKhansa Al-AzzamShatha ElemianHala Abu-FaresAreej Abu SheikhaHira Bani HaniRayan BaterBaha' SharafBrandie HealdEdward D EsplinSarah M NielsenMais AlkyamLama AbujamousAreej Al-Attary

Published in: Molecular genetics & genomic medicine (2022)

PGVs are common among Jordanian women with ovarian cancer, and mostly occur in BRCA1/2. Given its clinical impact on disease prevention and precision therapy, universal testing should be routinely offered.

Keyphrases

papillary thyroid
risk factors
stem cells
squamous cell carcinoma
young adults
mesenchymal stem cells
lymph node metastasis
cell therapy
replacement therapy